Solvaldi and “The Conversation” on New Drug Pricing: Are We There Yet? (Part II – Sovaldi and the Hepatitis C marketplace, 2014)
By Health Tech GPS |
We all know that someday, the US will need to tackle a long-avoided national “Conversation” on healthcare… the one that ...
Eyes on the Prize: It’s Not the Approval, It’s the Reimbursement
By Health Tech GPS |
Dear Friends: I apologize for falling behind in sharing any new blogposts in some time. I suppose everyone needs a ...
The Shutdown Ends! Or, does it?
By Health Tech GPS |
The Shutdown. The cliff. Okay, so the news pundits seem to say it’s over. We have a Continuing Resolution, a ...
Cologuard: Who’s really deciding Medicare’s reimbursement?
By Health Tech GPS |
Cologuard, the whiz-bang colon cancer test from Exact Sciences (EXAS), is the star of quite a three-ring circus in Washington ...